Healthcare | February 04, 2022
Sir HN Reliance Foundation Hospital partners with Karkinos Healthcare for community cancer screening
The target demographic will be those between the ages of 30 and 65 years
The target demographic will be those between the ages of 30 and 65 years
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
The covid health center will be managed and administered by the district administration of Ballari
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
Previously, the use of the drug was limited to patients requiring hospitalization
An article by a team of 12 Italian and 9 Russian scientists led by Francesco Vaia, Director of the Spallanzani Institute and Alexander Gintsburg, Director of the Gamaleya Center, has been published in medRxiv
Subscribe To Our Newsletter & Stay Updated
